Granular Therapeutics Limited
1 clinical trials · Sponsor
◉ Watch Granular Therapeutics Limited
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria (NCT07181369) | Granular Therapeutics Limited | 2025-10-06 |
Track Granular Therapeutics Limited automatically
Every clearance here is in the API, with alerts when new ones post.